Why did the Nasdaq fall?

The Nasdaq fell due to a decline in semiconductor stocks after TSMC's disappointing earnings.

What drove healthcare stocks higher?

Healthcare stocks rose on Merck's FDA approval and Eli Lilly's major acquisition.

Did TSMC's results affect the entire sector?

Yes, TSMC's earnings miss put pressure on the entire semiconductor sector.

What is Merck's new drug that received FDA approval?

The drug name was not disclosed in the report, but the approval was a key catalyst for the stock.

Nasdaq Falls as Chip Stocks Slide; Healthcare Rises

The Nasdaq index declined due to pressure on chip stocks after TSMC's earnings miss, while healthcare outperformed on Merck's FDA win and Eli Lilly's big buy.

The Nasdaq composite fell on Thursday as semiconductor stocks came under pressure following disappointing earnings from Taiwan Semiconductor Manufacturing Company (TSMC). In contrast, healthcare stocks rallied on positive news from Merck and Eli Lilly.

Market Moves

Semiconductor Sector

Chip stocks declined after TSMC reported quarterly results that missed analyst expectations, raising concerns about slowing demand for semiconductors. TSMC shares fell over 4%, dragging the Philadelphia Semiconductor Index (SOX) into negative territory.

Healthcare Sector

Healthcare stocks outperformed, driven by:

Merck (MRK): Received FDA approval for a new drug, sending shares up nearly 2%.
Eli Lilly (LLY): Announced a major acquisition of a biotech firm, boosting investor confidence in its growth strategy.
UnitedHealth (UNH): Rose in sympathy with the sector.

Broader Context

The moves come amid ongoing market volatility due to inflation and interest rate concerns. While tech remains under pressure, healthcare is seen as a relatively safe haven.

What It Means for Investors

The divergent performance suggests a potential rotation into defensive sectors like healthcare, while tech continues to face headwinds. Investors should monitor interest rate developments and upcoming earnings reports.